本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Seres Therapeutics, Inc.

0.6898
+0.05148.05%
盤後0.6600-0.0298-4.32%19:11 EDT
成交量:81.23萬
成交額:54.85萬
市值:1.18億
市盈率:-3.93
高:0.6900
開:0.6500
低:0.6400
收:0.6384
資料載入中...

公司資料

公司名字:
Seres Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2010
員工人數:
233
公司地址:
101 Cambridgepark Drive,Cambridge,Massachusetts,United States
郵編:
02140
電話:
傳真:
- -
簡介:
Seres Therapeutics, Inc.於2010年10月根據特拉華州法律註冊成立。該公司是一家商業階段的微生物組療法公司,專註於一類新型生物藥物的開發和商業化,這些藥物旨在通過調節微生物組來治療疾病,通過將被破壞的微生物組的功能修復到非疾病狀態來恢復健康。該公司還在設計微生物組療法,這些療法經過優化,可以去定植病原體並調節宿主功能,以減少和預防感染並誘導免疫耐受。

董事

名稱
職位
Eric D. Shaff
President, Chief Executive Officer and Director
Stephen Berenson
Chairman of the Board
Dennis A. Ausiello
Director
Gregory Behar
Director
Kurt C. Graves
Director
Meryl S. Zausner
Director
Paul R. Biondi
Director
Richard N. Kender
Director
Willard H. Dere
Director

股東

名稱
職位
Eric D. Shaff
President, Chief Executive Officer and Director
Marcus Chapman
Senior Vice President, Finance and Principal Financial and Accounting Officer
David S. Ege
Executive Vice President and Chief Technology Officer
Lisa von Moltke
Executive Vice President and Chief Medical Officer
Matthew Henn
Executive Vice President and Chief Scientific Officer
Teresa L. Young
Executive Vice President, Chief Commercial and Strategy Officer
Thomas J. DesRosier
Executive Vice President and Chief Legal Officer